Convano Inc. announced its full-year financial results for the fiscal year ending March 2026, reporting a massive 378.3% year-on-year revenue increase to 15.5 billion yen and a 49-fold jump in Non-GAAP operating profit to 6.6 billion yen. The growth was driven by its AI-powered SaaS recurring revenue model leveraging a network of over 500 medical institutions, alongside expanding consulting and healthcare businesses. The company projects 26.7 billion yen in revenue for FY2027 based on a conservative forecast.